Integrating primary palliative care into hidradenitis suppurativa management

By sjmartinez • December 27, 2022

Shih T, Zell M, Karlin D, De DR, Smogorzewski J, Shi VY, Hsiao JL. Integrating primary palliative care into hidradenitis suppurativa management. Int J Womens Dermatol. 2022 Dec 16;8(4):e063. doi: 10.1097/JW9.0000000000000063. PMID: 36567965; PMCID: PMC9760599.

Tags: Dermatology, General Internal Medicine, Harbor UCLA, hidradenitis suppurativa, palliative care, Palliative Care, prevention, Publications

Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60

Egeberg A, Hawkes JE, Somani N, Burge R, See K, Gallo G, McKean-Matthews M, Gooderham M, Han G, Armstrong A. Sustained Improvements in Clinical and[...]

Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials

Lebwohl M, Warren RB, Sofen H, Imafuku S, Paul C, Szepietowski JC, Spelman L, Passeron T, Vritzali E, Napoli A, Kisa RM, Buck A, Banerjee[...]

Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials

Merola JF, Armstrong A, Khattri S, Paek SY, Padilla B, Yue C, Photowala H, Kaplan B, Kristensen LE. Efficacy of risankizumab across subgroups in patients[...]